“…There has yet to be a global assessment of the impact of eye health, including vision impairment, eye disease and ophthalmic interventions on quality of life across the lifespan, despite the growing number of ophthalmic studies assessing quality of life, and increased value placed on patient-reported outcomes. Prior studies on vision and quality of life have usually focused on specific countries (eg, USA, 24 Finland, 25 South Korea, 26 Nigeria 27 ), populations (eg, Malay population in Singapore, 28 Latino population 29 and indigenous peoples of the Americas 30 in the USA) or settings (eg, community, 31 outpatient clinics 32 ). Even reviews summarising the evidence about the impact of vision on quality of life have usually focused on specific age groups (eg, children, 33 34 older adults 35 ), eye conditions (eg, glaucoma, 36 diabetic retinopathy, 37 dry eye 38 ) or interventions (eg, low vision rehabilitation for children, 34 anti-vascular endothelial growth factor therapy for age-related macular degeneration 39 ).…”